The scientist’s investigation covers issues in Fasciola hepatica, Liver fluke, Triclabendazole, Pathology and Trematoda. He works on Fasciola hepatica which deals in particular with Hepatica. His Liver fluke research incorporates elements of Fasciola and Drug resistance.
His studies deal with areas such as Veterinary medicine and Pharmacology, Drug as well as Triclabendazole. In his work, Syncytium, Stimulation and Cytoplasm is strongly intertwined with Viral tegument, which is a subfield of Pathology. The various areas that Ian Fairweather examines in his Trematoda study include Peripheral nervous system, Central nervous system and Anatomy.
His main research concerns Fasciola hepatica, Liver fluke, Triclabendazole, Pathology and Molecular biology. His studies in Fasciola hepatica integrate themes in fields like Ultrastructure, Trematoda, Viral tegument and Andrology. As a member of one scientific family, Ian Fairweather mostly works in the field of Liver fluke, focusing on Biochemistry and, on occasion, Ouabain.
He combines subjects such as Veterinary medicine, Anthelmintic, Pharmacology and Drug resistance with his study of Triclabendazole. Ian Fairweather has included themes like In vitro, Syncytium and In vivo in his Pathology study. His Molecular biology study incorporates themes from Tubulin, Immunocytochemistry and Pancreatic polypeptide.
Ian Fairweather spends much of his time researching Fasciola hepatica, Triclabendazole, Liver fluke, Pathology and Hepatica. His Fasciola hepatica study is related to the wider topic of Immunology. His Triclabendazole research integrates issues from Drug metabolism, Ovary, Drug resistance, Pharmacology and Histology.
His Liver fluke study which covers Incubation that intersects with Efflux. His Pathology research is multidisciplinary, relying on both Trematoda, Helminths, Viral tegument and Vacuole. His biological study spans a wide range of topics, including Antibody, Fasciolosis and Physiology.
His primary areas of investigation include Fasciola hepatica, Triclabendazole, Liver fluke, Veterinary medicine and Hepatica. His Fasciola hepatica research is multidisciplinary, incorporating elements of Ovary and Pathology. Ian Fairweather interconnects Trematoda, Andrology, Viral tegument and In vivo in the investigation of issues within Pathology.
His research integrates issues of Drug, Pharmacology, Drug metabolism, Molecular biology and Drug resistance in his study of Triclabendazole. His Veterinary medicine study combines topics from a wide range of disciplines, such as Climate effects, Food safety and Fasciola. His Hepatica study combines topics in areas such as Feces, Oxfendazole and Albendazole.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Drug resistance in veterinary helminths
Adrian J. Wolstenholme;Ian Fairweather;Roger Prichard;Georg von Samson-Himmelstjerna.
Trends in Parasitology (2004)
Fasciolicides: Efficacy, Actions, Resistance and its Management
Ian Fairweather;J.C. Boray.
Veterinary Journal (1999)
Understanding triclabendazole resistance.
G. P. Brennan;I. Fairweather;A. Trudgett;E. Hoey.
Experimental and Molecular Pathology (2007)
Triclabendazole: new skills to unravel an old(ish) enigma.
Journal of Helminthology (2005)
NEUROPEPTIDE-F - A NOVEL PARASITIC FLATWORM REGULATORY PEPTIDE FROM MONIEZIA-EXPANSA (CESTODA, CYCLOPHYLLIDEA)
Aaron Maule;Christopher Shaw;D W Halton;L. Thim.
Triclabendazole progress report, 2005-2009: an advancement of learning?
Journal of Helminthology (2009)
Reducing the future threat from (liver) fluke: realistic prospect or quixotic fantasy?
Veterinary Parasitology (2011)
Triclabendazole-resistant Fasciola hepatica: β-tubulin and response to in vitro treatment with triclabendazole
M. W. Robinson;A. Trudgett;E. M. Hoey;I. Fairweather.
The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica
Mark W. Robinson;Jill Lawson;Alan Trudgett;Elizabeth M. Hoey.
Parasitology Research (2004)
A possible model of benzimidazole binding to β-tubulin disclosed by invoking an inter-domain movement
Mark W. Robinson;Neil McFerran;Alan Trudgett;Liz Hoey.
Journal of Molecular Graphics & Modelling (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: